DiscoGel Injection in Iran

DiscoGel injection in Iran is a minimally invasive, image-guided procedure used in selected patients with symptomatic herniated intervertebral discs. Unlike an epidural injection, where medication is placed around the spinal nerves, DiscoGel is injected directly into the affected intervertebral disc under fluoroscopic or other imaging guidance.

DiscoGel is a radiopaque gel containing gelified ethanol, a cellulose derivative and tungsten, which allows the physician to visualize the material during injection. The treatment is intended to reduce pressure associated with selected disc herniations while preserving the basic structure of the intervertebral disc.

Patients considering DiscoGel treatment in Iran can use Tabeebo to explore pain medicine specialists, spine physicians and other providers offering this procedure, compare professional profiles and practice locations, and learn more about whether minimally invasive disc treatment may be suitable for their condition.

What Is DiscoGel?

DiscoGel is an implantable medical device administered through a needle directly into an intervertebral disc.

The gel contains a radiopaque component, tungsten, which makes it visible under X-ray imaging. This allows the physician to monitor the progression of the material during the procedure.

Its proposed mechanical action involves reducing water content and pressure within a protruding disc and creating a barrier within fissures of the disc. This may reduce irritation or compression affecting nearby nerve structures in appropriately selected patients.

The procedure is normally performed under imaging guidance and is considerably less invasive than open spinal surgery.

What Conditions Can DiscoGel Treat?

DiscoGel is primarily considered for patients with symptomatic disc herniation whose symptoms have not adequately improved with appropriate conservative treatment.

Symptoms associated with a herniated lumbar disc may include:

• lower back pain;
• pain radiating into the buttock or leg;
• sciatica;
• tingling or numbness;
• pain associated with irritation of a spinal nerve.

Importantly, finding a bulging or herniated disc on an MRI does not automatically mean that DiscoGel is appropriate. Disc abnormalities are common on imaging and may not be responsible for the patient's symptoms.

Clinical examination and imaging findings therefore need to correspond before an intradiscal treatment is considered.

DiscoGel for Lumbar Disc Herniation

The strongest established indication for DiscoGel injection is lumbar and lumbosacral disc herniation.

The treatment may be considered in selected patients who continue to experience disc-related or radicular symptoms despite conservative management but who do not necessarily require immediate open decompression or other spinal surgery.

Patient selection is particularly important. The size and type of herniation, condition of the intervertebral disc, neurological findings and degree of spinal or foraminal narrowing can all influence whether DiscoGel is appropriate.

Can DiscoGel Be Used for Cervical Disc Herniation?

DiscoGel has also been used for cervical disc herniation, including in published clinical experience from Iran.

However, treatment indications vary by jurisdiction and product authorization. The current European manufacturer information identifies lumbar and lumbosacral herniated discs as the formal indication, and the manufacturer notes that the cervical indication is no longer part of its current EU indication.

Patients considering DiscoGel for a cervical disc should therefore be evaluated individually by an experienced spine or interventional pain specialist and should ask whether this use is appropriate and authorized in the country where treatment is being provided.

How Is DiscoGel Injection Performed?

The procedure is performed using sterile technique and image guidance.

A typical treatment involves:

1. identifying the disc responsible for the patient's symptoms;
2. positioning the patient for safe access to the affected disc;
3. using local anesthesia and, when appropriate, sedation;
4. guiding a needle toward the center of the intervertebral disc;
5. confirming needle position using fluoroscopic imaging;
6. slowly injecting DiscoGel while monitoring its distribution; and
7. observing the patient after the procedure.

The procedure does not normally require the surgical removal of bone, ligaments or disc tissue.

The manufacturer describes DiscoGel treatment as commonly performed on an outpatient or day-hospital basis.

DiscoGel vs. Epidural Injection

DiscoGel and epidural steroid injections are different treatments.

An epidural injection generally delivers medication into the epidural space around irritated spinal nerves to reduce inflammation and pain. It does not place material inside the intervertebral disc.

DiscoGel, by contrast, is an intradiscal treatment. The needle enters the affected disc itself and the gel is injected into the disc under imaging guidance.

The choice between the two procedures depends on the source of the patient's symptoms, imaging findings and clinical assessment.

DiscoGel vs. Disc Surgery

DiscoGel may appeal to some patients because it avoids the larger incisions and tissue dissection associated with conventional spinal surgery.

However, it should not be described as a replacement for surgery in every patient.

Some disc herniations require surgical evaluation, particularly when there are significant or progressive neurological problems, severe structural abnormalities or other findings that make a percutaneous procedure inappropriate.

Conversely, many patients with disc herniation do not need either DiscoGel or surgery and improve with medication, activity modification, physiotherapy or other conservative treatments.

The objective is therefore to select the treatment that corresponds to the patient's specific diagnosis rather than simply choosing the least invasive procedure.

Who May Be a Candidate for DiscoGel?

Potential candidates may include selected patients who:

• have symptoms consistent with a herniated disc;
• have imaging findings that correspond to those symptoms;
• continue to have significant symptoms despite conservative treatment;
• have an intervertebral disc suitable for percutaneous treatment; and
• do not have a condition requiring a different or more urgent treatment.

Assessment may include a neurological examination and review of MRI or CT imaging.

DiscoGel should not be selected solely because a scan shows disc degeneration or a disc bulge.

Who Should Not Have DiscoGel?

According to current manufacturer information, DiscoGel is contraindicated in people with a known allergy to one of its components, during pregnancy, and in patients with immature intervertebral discs such as children.

Other anatomical or neurological findings may also make an intradiscal procedure unsuitable even when they are not product-specific contraindications.

Patients with significant weakness, neurological deterioration, bladder or bowel symptoms or other warning signs require prompt specialist assessment rather than relying on elective minimally invasive treatment.

Recovery After DiscoGel Injection

DiscoGel is commonly performed without a prolonged hospital stay. Patients are usually monitored after the procedure and may be able to leave the medical facility on the same day depending on their clinical condition.

Temporary discomfort or a burning sensation can occur during or after injection.

Return to normal activity varies between patients. The manufacturer describes symptomatic improvement as potentially developing over approximately three to six weeks, rather than necessarily occurring immediately after treatment.

The treating physician may recommend temporary restrictions on strenuous exercise, lifting and activities that place substantial stress on the spine, followed by gradual rehabilitation.

Risks and Possible Side Effects

Although DiscoGel is minimally invasive, it is still a medical procedure involving entry into the intervertebral disc.

Reported or manufacturer-listed potential adverse effects include:

• temporary pain or burning;
• temporary nerve-root irritation;
• temporary sensory or motor symptoms;
• leakage of gel outside the intended area;
• inflammatory reaction;
• disc infection or discitis;
• allergic reaction; and
• nerve or neurological injury.

Individual risks depend on the treated level, anatomy, technique and medical condition of the patient. These risks should be discussed with the treating physician before the procedure.

How Effective Is DiscoGel?

Published studies have reported improvement in pain and function in selected patients treated with radiopaque gelified ethanol, including studies conducted in Iran.

However, the strength of the evidence should not be overstated. Earlier health-technology assessments noted substantial variation between studies and limitations in the quality and size of the available evidence.

DiscoGel should therefore be presented as a treatment option for appropriately selected patients, not as a guaranteed cure for herniated discs.

DiscoGel Injection Cost in Iran

Price reference reviewed: August 26, 2026

As a general guide, DiscoGel injection in Iran may cost approximately US0–0 or more, depending on the case.

Published Iranian prices from 1404 reported approximately 20–40 million toman for treatment in some private centers. Because the Iranian currency and the cost of imported medical devices can change rapidly, Tabeebo presents the price in US dollars and timestamps the estimate rather than treating old toman prices as current tariffs.

The final cost can depend on:

• the number of discs treated;
• the amount of DiscoGel required;
• whether one or multiple spinal levels are treated;
• physician or interventional specialist fees;
• hospital or procedure-room charges;
• fluoroscopy or CT guidance;
• pre-procedure imaging and investigations;
• medications and sedation; and
• follow-up care.

Patients should therefore request a current written quote from the treating provider.

For comparison, the same treatment can cost considerably more in some European private healthcare systems, where current hospital price lists can run into several thousand euros.

Choosing a DiscoGel Specialist in Iran

Because DiscoGel is an image-guided intradiscal procedure, appropriate patient selection and accurate needle positioning are important.

When comparing doctors offering DiscoGel in Iran, patients may want to consider:

• specialty and training in interventional pain or spine procedures;
• experience with intradiscal interventions;
• professional registration and available credentials;
• the imaging guidance used during treatment;
• the hospital or medical facility where treatment is performed;
• who performs the procedure;
• how candidacy is assessed;
• availability of follow-up care; and
• what happens if symptoms fail to improve.

International patients should also confirm how long they need to remain in Iran and how follow-up will be managed after returning home.

Find DiscoGel Doctors in Iran

On this page, you can explore doctors offering DiscoGel injection in Iran and compare available information about their specialties, professional backgrounds, locations and services.

DiscoGel is not suitable for every person with back pain, sciatica or a herniated disc. A medical and imaging assessment is necessary to identify the source of symptoms and determine whether DiscoGel, conservative treatment, another interventional procedure or spinal surgery is the more appropriate option.

Tabeebo provides healthcare-provider information to support discovery and comparison and does not replace individual medical evaluation.